Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
Primary and Secondary Reinforcers01:23

Primary and Secondary Reinforcers

In psychology, reinforcement is a key concept in behavior modification. B.F. Skinner demonstrated this with his experiments involving rats in what is known as a Skinner box. The rats learned to press a lever to receive food, a primary reinforcer that fulfilled their innate need for nourishment.
Effective reinforcers for humans vary depending on the individual and the context. Primary reinforcers, such as food, water, sleep, shelter, and pleasure, have inherent value and satisfy basic biological...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.
Neurotransmitters01:30

Neurotransmitters

Neurotransmitters play a crucial role in the communication between neurons in the autonomic nervous system. Neurons in the autonomic nervous system can be cholinergic or adrenergic depending on the neurotransmitters synthesized. Cholinergic neurons use acetylcholine as their primary neurotransmitter. This includes all the preganglionic fibers of the sympathetic and pre- and postganglionic fibers of the parasympathetic nervous systems. In addition, neurons of the somatic nervous system also use...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fruquintinib in combination with tislelizumab versus trifluridine/tipiracil and bevacizumab in third-line and beyond MSS mCRC without active liver metastases-the IKF-080/AIO-QUINTIS trial.

ESMO gastrointestinal oncology·2026
Same author

Virtual reality support during systemic cancer therapy to improve anxiety/depressive symptoms and reduce toxicity in patients with gastrointestinal cancers-OncoVR.

ESMO gastrointestinal oncology·2026
Same author

TROPHIT1-a randomized, open-label, multicenter, phase II/III trial of sacituzumab govitecan compared to standard of care in metastatic colorectal cancer patients.

ESMO gastrointestinal oncology·2026
Same author

Preoperative immunotherapy with atezolizumab and tiragolumab in patients with colorectal liver metastases-the PURPLE trial.

ESMO gastrointestinal oncology·2026
Same author

Human <i>in vivo</i> assessment of ketamine binding of the serotonin transporter-follow up at a higher dose.

Frontiers in neuroscience·2025
Same author

Quality-adjusted survival in patients with metastatic colorectal cancer treated with fruquintinib plus best supportive care: results from FRESCO-2.

ESMO open·2025
Same journal

Chronic stress primes TLR3-mediated systemic inflammation to produce persistent post-viral fatigue syndrome-like symptoms in mice.

Neuroscience·2026
Same journal

Contribution of muscarinic acetylcholine receptors to bottom-up amplification of frontal and parietal cortical responses to rare deviant tones in rats.

Neuroscience·2026
Same journal

Developmental switch of GABAergic signaling in starburst amacrine cells driven by chloride transporter dynamics.

Neuroscience·2026
Same journal

Epileptiform discharges are associated with increased theta activity over time in patients with Lewy body dementia.

Neuroscience·2026
Same journal

Response times from gap detection threshold testing relate to cognitive processing speed in young adults.

Neuroscience·2026
Same journal

The timing of visual selective attention in fronto-parietal network: TMS behavioral and brain structural evidence.

Neuroscience·2026
See all related articles

Related Experiment Video

Updated: Jun 16, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Reward and the serotonergic system.

G S Kranz1, S Kasper, R Lanzenberger

  • 1Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria.

Neuroscience
|January 30, 2010
PubMed
Summary
This summary is machine-generated.

Serotonin plays a crucial role in processing rewards, influencing emotions and motivation. This neurotransmitter may be as vital as dopamine in understanding reward mechanisms and treating conditions like depression.

More Related Videos

Studying Food Reward and Motivation in Humans
12:09

Studying Food Reward and Motivation in Humans

Published on: March 19, 2014

Related Experiment Videos

Last Updated: Jun 16, 2026

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

Studying Food Reward and Motivation in Humans
12:09

Studying Food Reward and Motivation in Humans

Published on: March 19, 2014

Area of Science:

  • Neuroscience
  • Psychiatry
  • Neurobiology

Background:

  • Anhedonia, the inability to experience pleasure, is a core symptom in psychiatric disorders like depression and schizophrenia.
  • Reward processing research has historically focused on dopamine and opioid systems, largely overlooking serotonin.
  • Emerging evidence highlights serotonin's significant, yet underappreciated, role in reward mechanisms.

Purpose of the Study:

  • To review and synthesize current evidence on the serotonergic system's involvement in reward processing.
  • To highlight serotonin's role in emotional, motivational, and cognitive aspects of reward.
  • To argue for serotonin's importance in reward mechanisms, comparable to dopamine.

Main Methods:

  • Review of electrophysiological, pharmacological, genetic, and neuroimaging studies.
  • Analysis of primate research involving neuronal recordings in the dorsal raphe nucleus.
  • Examination of studies using intracranial self-stimulation and manipulation of extracellular serotonin levels.

Main Results:

  • Electrophysiological and primate studies suggest serotonin mediates reward value and motivational aspects.
  • Pharmacological studies demonstrate serotonin's influence on pleasure and aversion through receptor modulation.
  • Evidence indicates serotonin impacts emotional, motivational, and cognitive dimensions of reward representation.

Conclusions:

  • Serotonin is a fundamental mediator of reward processing, influencing its emotional, motivational, and cognitive components.
  • The serotonergic system's role in reward is as significant as that of the dopaminergic system.
  • Further research into serotonin's mechanisms is crucial for understanding and treating reward-related psychiatric disorders.